Clinical Trial

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics
Trial Details
NCT Number NCT04499755
Lead Sponsor Sherief Abd-Elsalam
Conditions Brain Injuries
Enrollment 100 participants
Start Date 2020-06-01
Primary Completion 2030-12-01 (estimated)
Study Completion 2030-12-10 (estimated)
Updated on ClinicalTrials.gov 2020-08-05